Author

A. A. Mamun

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. B. Hanker· 1 shared A. Marin· 1 shared B. P. Brown· 1 shared C. L. Arteaga· 1 shared d. R. Sudhan· 1 shared D. Ye· 1 shared H. Akamatsu· 1 shared J. Meiler· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. B. Hanker

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 23, 2022

Acquired secondary HER2 mutations enhance HER2/MAPK signaling and promote resistance to HER2 kinase inhibition in HER2-mutant breast cancer

A. Marin, A. A. Mamun, H. Akamatsu…·A. B. Hanker

This study identifies secondary HER2 mutations that confer resistance to HER2 kinase inhibitors in HER2-mutant breast cancer by enhancing HER2 signaling and reducing drug binding.

DOI 10.1101/2022.09.23.509246

humanbulk RNA-seq

𝕏 PostBluesky